| abstract |
Disclosed is a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein L and M are independently selected from -O-, -CH2-, -S-, -N(R)-N(R)-, -C(=O)- and -SO2-, and the remaining substituents are as defined in the specification. The compounds are useful for treating diseases caused by unregulated p38 MAP kinase activity. |